22nd Century Group, Inc (NASDAQ:XXII)

22nd Century Group, Inc. (22nd Century Group) is a holding company. The Company's wholly owned subsidiary, 22nd Century Limited, LLC (22nd Century Ltd), which is a plant biotechnology company. The Company's products include X-22 Smoking Cessation Aid, Modified Risk Cigarettes, BRAND A Cigarettes and BRAND B Cigarettes.On January 25, 2011, 22nd Century Limit ed, LLC (22nd Century Ltd) completed a reverse merger transaction (the Merger) with 22nd Century Group, and as a result,22nd Century Ltd became a wholly owned subsidiary of 22nd Century Group, which continues to operate the business of 22nd Century Ltd. the Company's drug application for X-22 was cleared by the UnitedStates Food and Drug Administration (FD A) in July 2011. In December 2013, 22nd Century Group Inc acquired an undisclosed manufacturing facility located in Mocksville, North Carolina. Effective December 11, 2013, 22nd Century Group Inc acquired NASCO Specialty Brands LLC.